Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort
Identification
- Clé publique
- radar:r-0a2eda78d64f54b10bea8cef2d7e2a5f
- Auteurs
- Christine M. Steeger · Poojashree Tandukar · Karin Ferneyhough Hoth · Mark S. Aloia · Fred Wamboldt · Peter J. Castaldi · Sunita Sharma · Nancy Lorenzon · Laura E. Crotty Alexander · Jost Klawitter · Cristina Sempio · Gregory L. Kinney · Meghan D. Althoff · Gina Rae Kruse · Russell Paul Bowler
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-14T02:03:31.242428+00:00
- Dernière observation des métadonnées
- 2026-11-14T02:03:31.242428+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
University of Colorado Boulder · Colorado State University Pueblo · University of Iowa · National Jewish Health · Harvard University · University of Denver · University of California San Diego · VA San Diego Healthcare System · University of Colorado Denver · Cleveland Clinic
Pays d’affiliation déclarés
US
Résumé documentaire — langue originale
BACKGROUND: Cannabis is commonly used as a self-prescribed treatment for anxiety and depression, but few studies have evaluated these associations using both validated mental health scales and biological cannabinoid markers. This study aimed to test associations between cannabis use frequency and symptoms of anxiety and depression, and to examine whether frequent cannabis users with high symptom scores were less likely to use FDA-approved medications. METHODS: This is a secondary analysis of a cross-sectional study on sleep and cannabis use, including 195 participants who completed the Hospital Anxiety and Depression Scale (HADS), Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), and self-reported cannabis use. Urinary tetrahydrocannabinol (THC) metabolites validated recent cannabis exposure. Regression models adjusted for demographic and clinical variables. RESULTS: Frequent cannabis use (≥ 15 uses in the past 30 days) vs. infrequent use (14 or fewer uses in the past 30 days) was associated with higher likelihood of anxiety, AOR = 1.06 (95% CI 1.01, 1.12), p < 0.01 for the BAI and AOR = 1.05 (95% CI 1.01, 1.09), p < 0.05 for the HADS-A. However, frequency of cannabis use was not associated with depression for either the HADS-D, AOR = 0.98 (95% CI 0.94, 1.05) or BDI-II, AOR = 0.98 (95% CI 0.92, 1.04), ps > 0.05. Use of FDA-approved anxiolytic or antidepressant medications did not significantly differ by non-use, infrequent, and frequent cannabis use groups (20% vs. 18.2% vs. 21.1% for anxiolytic-hypnotics and 14% vs. 9.1% vs. 11.4% for antidepressants), and urinary cannabinoid levels were not associated with symptom severity, all ps > 0.05. CONCLUSIONS: Elevated anxiety was common among frequent cannabis users, yet use of FDA-approved medications was infrequent in this group despite increased symptom burden. These results suggest that some individuals may turn to cannabis to manage their symptoms instead of using evidence-based treatments. Clinicians should consider the possibility that patients might substitute cannabis for prescription medications, and routinely screen cannabis users for untreated anxiety. Randomized studies are needed to determine causal associations between anxiety symptoms and cannabis use, including potential interactions with FDA-approved pharmacotherapies. Such evidence will inform clinical recommendations and policy on cannabis use and mental health.
Identifiants
- OPENALEX
- https://openalex.org/W4415281087
- DOI
- 10.1186/s42238-025-00327-2
- PMID
- https://pubmed.ncbi.nlm.nih.gov/41107903
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12535088
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- BioMed Central
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Christine M. Steeger; Poojashree Tandukar; Karin Ferneyhough Hoth; Mark S. Aloia; Fred Wamboldt; Peter J. Castaldi; Sunita Sharma; Nancy Lorenzon; Laura E. Crotty Alexander; Jost Klawitter; Cristina Sempio; Gregory L. Kinney; Meghan D. Althoff; Gina Rae Kruse; Russell Paul Bowler. Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. 2025. https://doi.org/10.1186/s42238-025-00327-2
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Christine M. Steeger; Poojashree Tandukar; Karin Ferneyhough Hoth; Mark S. Aloia; Fred Wamboldt; Peter J. Castaldi; Sunita Sharma; Nancy Lorenzon; Laura E. Crotty Alexander; Jost Klawitter; Cristina Sempio; Gregory L. Kinney; Meghan D. Althoff; Gina Rae Kruse; Russell Paul Bowler. (2025). Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. https://doi.org/10.1186/s42238-025-00327-2
- Chicago
- Christine M. Steeger; Poojashree Tandukar; Karin Ferneyhough Hoth; Mark S. Aloia; Fred Wamboldt; Peter J. Castaldi; Sunita Sharma; Nancy Lorenzon; Laura E. Crotty Alexander; Jost Klawitter; Cristina Sempio; Gregory L. Kinney; Meghan D. Althoff; Gina Rae Kruse; Russell Paul Bowler. Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. 2025. https://doi.org/10.1186/s42238-025-00327-2
- ISO 690
- Christine M. Steeger; Poojashree Tandukar; Karin Ferneyhough Hoth; Mark S. Aloia; Fred Wamboldt; Peter J. Castaldi; Sunita Sharma; Nancy Lorenzon; Laura E. Crotty Alexander; Jost Klawitter; Cristina Sempio; Gregory L. Kinney; Meghan D. Althoff; Gina Rae Kruse; Russell Paul Bowler. Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. 2025. https://doi.org/10.1186/s42238-025-00327-2
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. Frequency of cannabis use and symptoms of anxiety and depression: a cross-sectional analysis of the Colorado cannabis users health cohort. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-0a2eda78d64f54b10bea8cef2d7e2a5f/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.1186/s42238-025-00327-2
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.